Key statistics
As of last trade Novozymes A/S (NZM2:BRN) traded at 50.53, 5.60% above its 52-week low of 47.85, set on Oct 30, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 50.53 |
|---|---|
| High | 50.53 |
| Low | 50.53 |
| Bid | 50.18 |
| Offer | 50.43 |
| Previous close | 50.53 |
| Average volume | -- |
|---|---|
| Shares outstanding | 414.56m |
| Free float | 295.25m |
| P/E (TTM) | -- |
| Market cap | 159.88bn DKK |
| EPS (TTM) | -- |
| Annual div (ADY) | 0.5458 CHF |
|---|---|
| Annual div yield (ADY) | 1.08% |
| Div ex-date | Aug 25 2025 |
| Div pay-date | Aug 27 2025 |
Data delayed at least 15 minutes, as of Jan 26 2026.
More ▼
Announcements
- Trading by management and close relations of management
- Trading by management and close relations of management
- Major shareholder announcement
- Novonesis delivered 8% organic sales growth in the first nine months of 2025
- 8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.
- Trading by management and close relations of management
- Noma and Novonesis partner to scale deliciousness
- Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters
- Major shareholder announcement
- Trading by management and close relations of management
More ▼
